ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Defining 'Evidence Generation' Within Modern Clinical Trials

  Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.

• Combining Patient-Centric Technology and RWD For Comprehensive Evidence

  Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

• Reserving Data Integrity With Retrospective Manual Entry

  A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.

• 4 Ways Home Visits Support Successful Rare Disease Clinical Trials

  Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.

• Navigating The eCOA Vendor Landscape In 2025

  This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.

• What Everest Group's RTSM Recognition Means For The Industry

  RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.

• Biosample Tracking: A Consenting Dilemma

  Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

• The Power Of Adaptive Learning

  Delve into the details of this approach to training, which addresses common complaints, and how it holds promise for enhancing the efficiency and performance of clinical research staff.

• Supporting Early Phase Oncology Research With The Right Data Management System

  Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.